** Shares of diagnostic company DermTech sink more than 57% to 14 cents premarket
** Co filed for Chapter 11 bankruptcy protection and plans to sell substantially all of its assets
** Court filing shows DMTK has listed estimated assets and liabilities in range of $50 mln-$100 mln
** DMTK also cut 15 jobs, could reduce more in the future
** Co intends to continue its laboratory operations and processing orders for its cancer diagnostic tests during bankruptcy proceedings
** As of last close, stock has already tumbled 81% YTD
(Reporting by Pratik Jain in Bengaluru)
((Pratik.Jain@thomsonreuters.com))
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.
Comments